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PREFACE
The Expression and Role of Fibroblast Growth Factor Receptors in
Xenopus laevis Regenerating Hindlimbs.

Name: Christopher Alan D’Jamoos
University of Dayton, 1997

Limb regeneration is a complex phenomenon that occurs in amphibians such as,
urodeles and anurans. This complicated process has been well characterized
*
morphologically in the salamander and frog species. However, only recent studies have

been aimed at the molecular and cellular level. In pursuing research to identify signals
involved in the process of limb regeneration, I have used the Xenopus laevis system,

since it is capable of regenerating limbs only during its tadpole stages and loses this
ability as it approaches metamorphosis. This study provides a descriptive analysis of the
expression of genes coding for Fibroblast Growth Factor Receptors (FGFRs) which have

been recognized as key signals during both limb development and regeneration. In this

study, we present the expression patterns of five FGFRs in pre-metamorphic
(regenerating) and post-metamorphic (non-regenerating) hindlimb outgrowths resulting
after amputation. Demonstrating differences in receptor expression, we devised

functional studies using inhibitors and tissue transplantation to illustrate the importance
of these signals during the limb regeneration process.
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REVIEW OF LITERATURE

Limb Regeneration: Models.

Some amphibians, in contrast to reptiles, birds and mammals have the ability

to replace a severed limb. Spallanzani (1769) first reported that salamanders are
capable of regeneration, the ability to restore an injured or amputated body part.

Urodeles are amphibians that keep their tails; such as the newt Notophthalamus

viridescens, and can regenerate an amputated limb during either their larval or

adult life, whereas the anuran (tailless), such as the Xenopus laevis, can
regenerate a limb only during its tadpole stages (Korneluk and Liversage, 1984).
Although mammals have not been found to possess regenerative abilities, the

process of limb regeneration in amphibians has been compared to tissue
regeneration at the distal tips of the phalanges in both mice and humans and
wound healing in mammals (Borgens, 1982; Ord & Stocken,1984; Reginelli et

al., 1995).

Limb regeneration and development demonstrate similar patterns.

The principles that regulate patterning of the regenerating limb may be

similar to those involved in patterning during initial limb development (Cohn and
Tickle, 1996). The first event in the regenerative process is the covering of the

wound by specialized epithelial cells, which is a process known as wound
healing. This process is extremely important to the manufacturing of the

necessary signals that will be incorporated in the wound epithelium. It is well
known that if this wound covering is prevented, either by covering the tissue with
1

grafted tissue or by the insertion of the amputated limb into the gut, no

regeneration occurs (Goss, 1956). Wound healing begins immediately after

amputation and discontinues once the wound epithelium has formed its covering.

Following wound epithelium formation, a blastema forms through the

dedifferentiation of muscle, cartilage and nerve cells, and mesodermal tissues
(original stump tissues) become undifferentiated mesenchymal cells (Driesch,

1902). This blastema then enlarges due to cellular proliferation and eventually

the cells redifferentiate into specific tissues that reconstitute the amputated part
(Butler, 1933).
The basic similarity between limb regeneration and limb pattern development

is based on the formation of this blastema. The blastema resembles embryonic

cells present during normal limb development and has the capacity to differentiate
into specialized cells. Muneoka and Bryant (1982) through transplantation

experiments with the regenerating axolotl Amblystoma mexicanum demonstrated

that the patterning mechanisms involved in the developing and regenerating limb
are similar. They were able to show that normal limbs formed from ipsilateral

grafts of limb bud/limb bud and limb bud/blastema, but supernumerary limbs

formed through contralateral grafts. This suggests that something common to

both developing and regenerating limbs provide for the pattern signals to the
limb. In the developing chick wing and the regenerating limb, epithelium tissue

proliferates to form an apical ectodermal ridge (AER; developing wings/limbs) or
a wound epithelium (also called epidermal cap in regenerating limbs) that caps

the wing/limb bud (Zwilling, 1955; Fallon and Lopez, 1994). It is this covering
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that signal the underlying cells to proliferate in both systems. The developing
limb bud consists of mesenchymal cells that undergo proliferation and

differentiation enabling the patterning and establishment of an entire limb
(Chevallier et al., 1977; Geduspan and Solursh, 1992).

The regenerating blastema consists of dedifferentiated tissue that

redifferentiates into mesenchymal tissue. Spallanzani (1769), Morgan (1901) and
many others have indicated that skeletal elements formed during limb

regeneration are histologically similar to those present in developing limbs. On
the cellular level, ultrastructural studies provide similarities between the
regenerating blastema and the embryonic limb bud (Bryant et al., 1971; Bryant et

al., 1977; Muneoka and Bryant, 1982). Their findings also suggest that muscle
differentiation follows similar patterns between development and regeneration in

limbs. However, differences exist at the molecular level. Tassava et al. (1993),
Estrada et al. (1993), and Tassava and Acton (1989) have recognized certain

antigens: such as WE3, WE4 and WE6 expresses in the wound epithelium and
have been functionally studied and believed to be involved in secretion and cell

adhesion processes. WE3 and WE4 have been implicated as actin-binding
proteins and WE6 has been identified as keratin. These proteins, although

present, most likely are not the signals for initiating limb regeneration; thus, the
search for the molecular signals responsible for triggering dedifferentiation and

regeneration are currently being investigated.

3

FGFs and FGFRs likely play roles in the regeneration process.

Fibroblast growth factors (FGFs) and FGF receptors (FGFRs) likely play roles
in amphibian limb regeneration and pattern formation in development. Members
of the FGF family have been found to be present in the newt wound epithelium

(FGFR-1 and FGFR-2, Poulin, et al., 1993; Poulin, and Chiu, 1995) and

mesenchyme (Hondermarck and Biolly, 1990; Boilly et al., 1991). These
molecules also have been implicated in the function of the limb bud AER in
vertebrate systems (Orr-Urtreger et al., 1991; Herbert et al., 1990). FGF-2 has
been found to induce regeneration in the chick wing bud when applied locally to

the amputation site (Taylor et al., 1994). Niswander et al. (1993) and Vogel et al.

(1995) have demonstrated that in the absence of an AER (the ectodermal tissue
which directs the growth of the normal limb/wing) in chick wing buds, FGF is

capable of replacing AER function by inducing the process of growth and pattern
formation. It is apparent that these signals have induction capability and may be
the target signals that initiate the regeneration process.

Characterization of FGF and FGFRs.

The FGF family consists of at least ten related genes (FGF 1-FGF 10) that are
classified on the basis of conserved coding sequences (Johnson and Williams,
1993; Emoto et al., 1997). FGF is a small polypeptide (13 Kda) that was first

isolated by Gospodarowicz (1974) and was shown to be mitogenic in 3T3 cells.
Since then, FGF protein-receptor interactions have been recognized in a number

4

of different mechanisms of action, such as, proliferation, differentiation, and

mesoderm induction, which depend on the cell type and the receptors involved

(Femig and Gallagher, 1994). This multifunctional characteristic of FGF is what
distinguishes it from the other growth factor members (Johnson and Williams,
1993).

Most FGFs are secreted and affect target cells by binding to one of five

known FGF receptors (FGFR1, FGFR2, FGFR3, FGFR4a and FGFR-4b) and

eventually activates transcription factors that provide a nuclear response. The
actual number of FGFs and FGFRs is actually much greater, since there are
alternative translation initiation sites for the FGF ligands and multiple alternative
splicing forms of these receptors (Johnson et al., 1991).

A clarification of nomenclature for different FGF and FGFR became
necessary when discoveries of multivariant genes were recognized (Table 1). Our
discussion will focus primarily on the five receptors because they will be the
focus of our investigation. FGFR-1 was first isolated from chicken embryos

using radiolabeled FGF-1 and FGF-2 (Lee et al., 1989). Since then, it has also

been isolated from human; h2, h3, or fig (Dionne et al., 1990), in the mouse;
designated fig as well (Mansukhani et al., 1990), and Xenopus-, xFGFR-1 (Musci
et al., 1990). Following the discovery of these genes, FGFR-2 (Freisel and
Dawid, 1991), FGFR-3 (Keegan et al., 1991), FGFR-4 (Partanen et al., 1991),

and FGFR4b (Dr. I. Hongo, Japan-not published) have been cloned in these

systems. There is approximately 50-75% sequence homology amongst these
receptors. Moreover, the receptor sequence homologies between species are quite
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high: 98% between human/mouse and 88% human/XewopMS (Freisel and Maciag,
1995, Patrie et al., 1995). FGFRs’ structure can provide clues to its binding

affinities for specific ligands as well as their mode of action. Each receptor, has
an intracellular tyrosine kinase located at its C-terminal that binds substrates. Its

extracytoplasmic region contains a 14 amino acid kinase insert domain that has

different binding affinities for FGFs based on the immunoglobulin (Ig)-like
domains (Johnson et al., 1991).

Alternative Splicing and Ligand Specificity

Structural variants of these receptors are produced through alternative splicing
of their RNA transcripts and appear to occur in a cell and tissue specific manner
(Table 1). The first loop may or may not be excised leaving two or three loop

receptor variants proposing no alteration in binding, and at the present time has

not been functionally characterized. The genes for FGFR-1, 2, and 3 contain
three mutually exclusive and consecutive exons that encode the 3 ’ half of the last
Ig loop (Robbie, 1995). When a FGFR contains three Ig-like domains it is called

an alpha (a) type; if it has only the second and third loop it is designated beta (p);

and when it is missing a secretory signal it is called gamma (y; Johnson and
Williams, 1993). The Ig-like domain is the binding site for FGF ligands.

Alternative splicing also results in structural differences in tyrosine kinase

domains (Shi et al., 1993). FGFR-1, FGFR-2 and FGFR-4 have membrane bound
localization; whereas, FGFR-3 has been found to be localized in the nucleus of

breast epithelial cells (Johnston et al., 1995). Splice variants of FGFR-1 and
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FGFR-2 also have been identified that give rise to secreted protein forms of the

extracellular ligand binding domain (Freisel and Maciag, 1995).
FGFs are known to exert their effects through high affinity binding to

receptors on the surface of cells (Dohrman et al, 1993). These proteins can bind

to multiple receptors with different binding affinities, allowing for tissue specific
regulation in response to FGF action. FGF binding is accomplished with the aid

of proteoglycans, namely heparin, heparinase and heparin sulfate (HS) (Gao and
Goldfarb, 1995; Itoh and Sokol, 1994; Kan et al., 1993). These molecules act to

bind several FGF ligands, forming a web that cross-links and dimerizes receptors.
The binding site for HS-FGF on FGFRs spans the second to approximately half
the third loop and has no variant forms; whereas, loop III has three receptor
forms: Ilia. Illb, and IIIc (Spivak-Kroizman, 1994). A receptor that only

contains Ilia, thus a Ilia variant, is a secretor variant, while those variants that
differ in their Illb and IIIc combinations provide an alteration in binding

specificity for ligands . The activation of FGF on cells also can be accomplished
by membrane bound low affinity glycosaminoglycan co-receptors (GAG) that are

composed of a linear heteropolysaccaride bound to a proteoglycan with its sugars
sulfated providing high charges (Jackson et al., 1991).

FGFR Signaling.

The signaling pathway and activation of these FGF receptors involves ligand-

receptor binding (Patrie et al., 1995). Binding of a ligand causes the receptors to
dimerize, initiating a conformational change that results in the activation of

7

protein tyrosine kinase (PTK) The protein kinase domains phosphorylate each

other to initiate downstream signaling (Burgess and Maciag, 1989). Every point
in this system is crucial to the activation of transcription factors. If the ligand
does not bind, most signals are discontinued. Dimerization has been recognized
as important in catalytic events. The complexity of regulation of FGFRs comes

from differences in their catalytic domains (Shi et al., 1993). There are two forms

of FGFR, one with a full catalytic kinase domain (form 1), and the other with a
truncated catalytic domain (form 2; Spivak-Kroizman, 1994). When 1-1 Forms

dimerize catalytic domains are fully functional, 2-2 dimers are silent, and 1-2

pairs are relatively inactive, although some have slight action (Shi et al., 1993).
Since we will be using the tyrosine kinase domain as a point of manipulation to

functionally inhibit FGFR signaling, it is important to describe the structure and

pathways of these PTK groups.
Protein kinases impart their activity by binding or orienting their substrate

site (intracellular receptor protein region with a Src homology 2 domain (SH2)
with a phosphate donor that is either ATP or GTP complexed with a cation (Mg+^

or Mn++; Amaya et al., 1991). A phosphate is then transferred from the donor to
the hydroxyl acceptor residue (serine, threonine, or in the case of FGFRs,

tyrosine) of the substrate (Yaish et al., 1988). There are two general classes of
PTK’s: the receptor tyrosine kinase that contains an extracellular ligand binding

and intracellular calalytic domain with intrinsic kinase activity, and the receptor
associated tyrosine kinase that transmit signals from the membrane receptor by

interacting with cytoplasmic membrane proteins (Freisel and Maciag, 1995).
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Three signaling processes are currently known to occur in PTK systems. The
first pathway involves autophosphorlyation triggering the Ras and the MAP

kinase cascade eventually initiating transcription factors that regulate genes

involved in the cell cycle (Haung et al., 1995; Johnson and Williams, 1993).
This pathway has been mostly found to be characteristic in cell proliferation and

tumor formation. A second PTK pathway involves the activation of a G-protein
which stimulates phospholipase C (PLC) to splits phosphatidylinositol 4,5-

biphosphate (PIP2) into two second messengers: inositol 1,4,5-triphospate (IP3)
and diacylglycerol (DAG; Shilling et al., 1994). This process eventually leads to

the release of calcium and the activation of protein kinases on the receptor
processes. Since this pathway involves the use of secondary messengers, it most

likely involves differentiation (Femig and Gallagher, 1994). The third pathway
causes the phosphorylation of the statl transcription factors and allows protein

translocation into the nucleus. This method of PTK signal transduction has not
yet been characterized with function for FGF processes, but is probably also
involved in the regulation of the cell cycle, cell growth and differentiation

(Mckeehan and Kan, 1994). A major phosphorylation site on FGFR-1 is Tyr766

at the carboxy terminus. This site has also been identified as the src homology
(SH) 2 domain in PLC (Ryan and Gillespie, 1994). Another major

autophosphorylation site has been localized at Tyr653 and is phosphorylated by
intermolecular mechanisms, as opposed to the intramolecular activation of

Tyr766 (Hou et al., 1993).
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FGFR Inhibitors.

Recently, commercial companies (Calbiochem, La Jolla, Ca. and Sugen Inc.,
San Francisco, Ca) and researchers have developed kinase inhibitors to
understand these signaling pathways and how they affect cell regulation. There

are two groups of competitive inhibitors aimed at two areas in the signaling
processes. One group of inhibitors acts on the catalytic domain by using a

pseudosubstate sequence to prevent substrate interactions and the other group acts
on the regulatory domains by blocking the activity of ATP/GTPase either through

binding to the regulatory domain or inhibiting cofactor binding (Levitzki, 1990).

The difficulty with using these inhibitors to evaluate function is that they

sometimes affect other processes through non-specific actions on a given system

in vivo.
Tyrophostin-A23 (3,4-dihydroxybenzylidene malononitrile; figure 1 A) is a

potent and broad ranged PTK inhibitor that primarily focuses on epidermal

growth factor; however, it has been found that Tyrophostin A-23 is unstable in

solution and that its derivatives are potent src tyrosine kinase inhibitors (Ramdas
et al., 1995). In vitro experimentation has shown these derivatives to be an

effective inhibitor of FGF receptor activity at a Ki (concentration constant) of 20-

35 pM, EGF receptor at a Ki of 45 pM as well as others reviewed by Ramdas et

al. (1995). These derivatives as well as Tyrophostin A-23 act by competitively

inhibiting the substrate site of the tyrosine kinase receptor.
Oxindole-based compounds (also called Indolinones) are a new class of
protein tyrosine kinase inhibitors that demonstrate the ability to inhibit the
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tyrosine kinase action of FGFR-1, PDGF (Mohammadi et al., 1997) and FGFR-2

(McMahon, Sugen, Inc. San Francisco, Ca., 1997-unpublished). SU4984 (3-(4-

(l-formylpiperazine-4-yl)-benzylidenzyl)-2-indolinone; figure IB) blocked the
tyrosine kinase activity of the FGFR in 3T3 NIH cells at a Ki of 20-40pM as well

as platelet derived growth factor and the insulin receptor, but not the epidermal
growth factor (Mohammadi et al., 1997). Oxindole based inhibitors, namely
SU5402, SU4984, SU76516, SU76568 and SU76636 were given to us by Dr.
McMahon from Sugen, Inc. in California. SU76516, SU76568 and SU76636 have
not been characterized to date, but their inhibition is believed to be much more

specific to FGFR-1 and FGFR-2 than SU4894 and SU5402 has been

demonstrated strongly and specifically inhibit FGFRs at a concentration between
10-20pM (McMahon, unpublished and Mohammadi et al., 1997). Indolinones

act to inhibit the kinase activity of FGFR-1, affecting the catalytic (competitive
inhibitor of the ATP site) domain of the receptors.

FGFRs involvement in various human diseases.

FGFR have been identified in various human diseases involving limb and
craniofacial development. A mutation in FGFR-1 can cause Pfeifer syndrome

that is characterized by limb defects and abnormal skull and facial shape due to

premature differentiation of cartilage and bone (Cross and Dexter, 1991). FGFR2 has been identified as the gene responsible for Crouzon, Jackson-Weiss, and

Apert syndromes (Su, 1997; Bellus et al., 1995). All of these syndromes are
caused by gene mutations altering normal development and causes limb and facial
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defects (Park et al., 1995). Mutations in FGFR-3 can cause achondroplasia
resulting in dwarfism which can be lethal (Bellus et al., 1995; Tavormina, 1995).
In these cases, FGFR appears to be turned on, without the necessity of a signal or
FGF ligand, preventing cartilage growth. However, when FGFR-3 gene knockout

in mice was performed, and expansion of endochondrial growth occurs,

suggesting that other mechanisms and genes are involved (Su, 1997).

FGF and FGFR expression and action in limb development.

In the developing chicken limb bud, FGF signals from the AER are necessary
for normal outgrowth and patterning of the limb (Niswander et al., 1993). FGFs
are believed to be the mitogenic signal present in the AER that induces cells to
differentiate during limb development. When chick limb mesenchyme is placed

in cell culture at clonal density with FGF-2, muscle differentiation increases and

the terminal differentiation of myoblasts is inhibited (Goldfarb, 1991). As
growth of the limb occurs in vivo, posterior cells are the first to leave the area
under the AER (progress zone) and to differentiate. These cells migrate in a

proximal to distal direction. When the AER is removed, cell growth is inhibited,

however, when FGF-2 (also called bFGF) or FGF-4 is introduced to these limb
bud cells, growth continues (Fallon et al., 1994; Niswander et al., 1993). When
beads soaked in FGF 1,2, and 4 were placed in the lateral plate mesoderm

opposite somites 20-26 in chick embryos, they were stimulated to produce
additional limbs (Cohn et al., 1995). FGF-8 is believed to be involved in

mitogenesis, signaling for the proliferation of the underlying mesenchymal cells,
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causing limb elongation (Crossley et al., 1996; MacArthur et al., 1995; Mahmood
et al., 1995; Vogel et al., 1996).

The developing mouse has been shown through \n situ hybridization studies

to express FGFR-1 (fig) and FGFR-2 (bek) mRNA in the lateral mesoderm and

the limb bud mesenchyme (Orr-Urtreger et al., 1991). bek appeared to be
localized in the surface ectoderm and chondrocytes in the developing limb
expressing strongest in the interdigital web, whereas fig seems to be distributed in

the mesenchyme. FGFR-3 expression appears to be primarily found in the
cartilage rudiments of developing bone, around the periosteum during
endochondrial ossification and in resting cartilage (Peters et al., 1993). Northern

blot expression studies demonstrated that FGFR-4 appears to be moderate in fetal
human striated muscle, pancreas and adrenal gland (Partanen et al., 1991; Stark et

al., 1991). Only FGFR-4 can be induced by heparin alone to dimerize and

autophosphoryl ate; however, the role of heparin to induce physiological changes
is still uncertain (Femig and Gallagher, 1994). Newborn mice that were

transgenic for FGFR-1 were bom without lungs (Park et al., 1995; Herbert et al..

1990). These studies demonstrate that FGF and its receptors are expressed in a

tissue specific manner and that it is crucial to understand how they relate to the
developmental process.
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FGF and FGFR presence in limb regeneration.

Related to the roles of FGFs in limb development, the presence of FGF and its
receptors has been studied during limb regeneration processes in the axolotl

Amblystoma mexicanum and in the newt, Notophthalmus viridescens, to ascertain
FGF’s role. In the axolotl, FGF-1 has been found to be present in the wound

epithelium and the mesenchyme (Boilly et al., 1991; Hondermarck and Boilly,

1990) and its receptor-ligand binding is heparinase sensitive (Forough et al.,
1991; Itoh and Sikol, 1994). FGF receptors have been found to be spatially and
temporally distributed in a specific manner in the regenerating newt limb (Poulin

et al., 1993). During the blastema stages of regeneration, FGFR2 expression is
localized in the wound epithelium basal layer and in the perichondrium (bone cell
precursors). Alternative spicing of FGFR2 produces two different transcripts,

KGFR and bek. These two isoforms delineate more specific expression patterns

present during the stages of regeneration associated with growth and blastema cell

proliferation. These transcripts differ in the second half of the third Ig-like loop
domain, and their expression is present in different tissues at different times in the
regeneration process. In the pre-blastema stage, the KGFR mRNA transcript is
present only in the basal layer of the wound epithelium, whereas the bek

expression is first presented in the perichondrium, then as regeneration progresses

its presence is in the mesenchyme. In contrast, FGFR1 was expressed

exclusively in the blastema mesenchymal cells (Poulin et al., 1993; Poulin and
Chiu, 1995).
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Xenopus laevis offers a system to study limb regeneration.
Although the newt has been an exceptional model system to study the limb
regeneration, Xenopus laevis limb regeneration only exists during the early
tadpole stages and loses this ability after metamorphosis. In 1962, Dent has

described the process of Xenopus limb regeneration in detail, providing evidence

that as Xenopus increases in age, it loses its ability for complete regeneration.

The later the amputation takes place during its tadpole stages the more incomplete
the regeneration. If the animal is amputated postmetamorphically (stage 59 and

older), it only forms a cartilagenous (hypomorphic) spike; therefore, this system
offers us a means to discriminate those signals that no longer are present when

regenerative ability is lost.

Limb patterning and regeneration in the Xenopus laevis hindlimb.
Since staging the animals for limb regeneration is crucial to our experiments,

it is necessary to briefly describe the developmental process of the limb in

Xenopus laevis in accordance to Nieuwkoop and Faber (1976). In its early stages,

specifically stages 48 through 50 (approximately 7.5-16 days after fertilization),
the hindlimb becomes apparent as a semicircular bud with a conical definition on

its distal side. At stages 51 through 53 (approximately 17-25 days post
fertilization), the hindlimb becomes more cone-like and paddle shaped with slight
indications of a flat foot, increasing in length rather than width. It is at this

developmental stage that the limb becomes pigmented, forming melanophores,
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and develops a 4th and a 5th toe. This is the point at which amputation would
provide complete limb regeneration. At stages 54 through 59 (26-45 days post

fertilization), the tadpole hindlimb grows to its full nature. Xenopus laevis,

during its normal and final stages of limb development, grows 3 black clawed

digits, and the fourth and fifth digits remain unclawed. The limb being extremely
small and delicate is not the only indicator in the staging process. The tentacles
are also helpful in aging the tadpoles, because they become longer at the end of
stage 53 and decreased in length as they approached metamorphosis at the end of

stage 59.
The anuran process of regeneration after a mid-shank amputation at stage 53 to

55 (Nieuwkoop and Faber. 1976) follows that of normal urodele (newt)

regeneration: wound covering, dedifferentiation, cell proliferation,

redifferentiation and maintenance of growth, and termination of growth (Butler,
1933). As mentioned above, the wound epithelium is considered to be the initiator

of the regeneration process by providing the signal to cells underneath it to
dedifferentiate and form a blastema (Stocum, 1984; Tsonis, 1996). We believe
that FGF and FGFR are likely candidates for such signals.
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Research Objectives.
This comparative study between regenerative (pre-metamorphic) and non-

regenerative (post-metamorphic) stages that are present during Xenopus laevis
hindlimb regeneration was designed to pinpoint possible factors that might
initiate the limb regeneration process and lead us toward discovering the

mechanisms involved in tissue regeneration in vertebrates. We therefore,
examined the expression of five FGFRs during Xenopus laevis ’ pre-metamorphic

stages (tadpole stages); a developmental time in which limb regeneration is

permissive, and post-metamorphic stages (froglet stage); a period in which this
ability is lost, in order to correlate expression patterns with regenerative ability.

Here, we conclusively show that expression does relate to the regulation of this

process. We have further studied the role of these receptors by using specific
inhibitors. Our study implicates FGFR-1 and FGFR-2 as the major players, which
regulate the ability for limb regeneration.
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ABSTRACT

During outgrowth of the developing limb, signals from the apical ectodermal
ridge (AER), such as Fibroblast Growth Factors (FGF), are paramount for limb

patterning. Similarly, FGF molecules and their receptors are synthesized in the
wound epithelium of the regenerating limb blastema, implicating an analogous

function to limb development. To address this issue further and to fathom the role
of FGFR signaling in limb regeneration, we have examined the expression
patterns of xFGFR-1, xFGFR-2, xFGFR-3, xFGFR-4a and xFGFR-4b in Xenopus
laevis. This amphibian model provides a system where both regenerating (pre-

metamorphic; tadpole or larva stage) and non-regenerating (post-metamorphic;
froglet stage) hindlimbs can be studied. In pre-metamorphic hindlimbs
(stage 53) all the receptors were expressed in the wound epithelium and the

underlying mesenchyme. In post-metamorphic limbs (stage 61), however,
transcripts for xFGFR-1 and xFGFR-2 were absent from the wound epithelium.

The expression results for xFGFR-1 and xFGFR-2 were corroborated at the
protein level by employing specific antibodies. Thus, it appears that both

FGFR-1 and FGFR-2 are the prime candidates involved in the outgrowth

signaling during the regeneration process. FGFRs role in regeneration was
further investigated by using specific inhibitors to FGFRs during premetamorphic regeneration. These compounds inhibited the normal limb

outgrowth and resulted in the majority of the cases, to generate cones and spikes
reminiscent of growth that is seen in amputated post-metamorphic limbs. Lastly,

since the FGFR signals expression differences are derived from the wound
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epithelium, we have preliminary results demonstrating the successful
transplantation and conversion of post-metamorphic limbs to recapture their

regenerative ability. These results are discussed in relation to future regenerative
models and the possibilities of inducing regeneration in non-regenerative systems.
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INTRODUCTION

Urodeles and anurans are two commonly used systems to study limb
regeneration. Urodeles, such as the newt Notophthalmus viridescens can
regenerate an amputated limb during either its larval or adult life (Tsonis, 1991),

whereas the anuran Xenopus laevis can regenerate its limb only during the tadpole

stage (Bossilico et al., 1992; Korneluk and Liversage, 1984). The first event in the
regenerative process is the covering of the wound by specialized epithelial cells,
then the muscle, cartilage, nerve cells and mesodermal tissues become
undifferentiated mesenchymal cells forming a blastema (Driesch, 1902). This

blastema then enlarges due to cellular proliferation and eventually redifferentiates

into specific tissue cells that reconstitute the amputated part (Butler, 1933; Tsonis,
1996). Xenopus laevis ’ intrinsic ability for limb regeneration during stage 52-55

(pre-metamorphic; stages delineated according to Nieuwkoop and Faber, 1976)
discontinues at the onset of metamorphosis at stage 59 (post-metamorphic). At
this stage of development, the limb is non-regenerative and grows a cartilagenous

stump. Although the newt has been an excellent model to study limb regeneration,

Xenopus laevis offers a system containing both regenerative and non-regenerative
limb capacities, therefore, it can be used to comparatively reveal differences in

signal presence or specific gene expression correlated with the ability for limb
regeneration.

Fibroblast Growth Factors (FGFs) and FGF receptors (FGFRs) could provide
signals that might play a crucial role in limb regeneration and pattern formation.
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The FGF family consists of at least ten related genes (FGF 1-FGF 10; reviewed in
Johnson and Williams, 1993; Emoto et al., 1997) and are small polypeptides («13
Kda, Gospodarowicz, 1974). Most FGFs are secreted and affect target cells by
binding to one of five known FGF receptors (xFGFR-1, xFGFR-2, xFGFR-3,

xFGFR-4a and xFGFR-4b). Members of the FGF family and their receptors are
present in the wound epithelium (Boilly, B. 1991; Poulin et al., 1993; Poulin and

Chiu, 1995). Although their regulatory roles for limb outgrowth and patterning in
regeneration are not fully understood, evidence has been presented from other

systems and imply that FGFs are imperative signals for this process. In

particular, during chick limb bud development, signals from the apical ectodermal

ridge (AER; the equivalent of the wound epithelium during newt limb
regeneration) are responsible for supporting limb outgrowth. Removal of the

AER inhibits limb development, but when FGF soaked beads are added into
AER-less limb buds, outgrowth is restored (Niswander et al., 1993). Therefore,

by analogy, these factors could be the important factors for the initiation of the
limb regeneration process as well.
Several studies using the axolotl, Amblystoma mexicanum, and the newt,
Notophthalmus viridescens, have shown the presence of FGFs and FGFRs in the

wound epithelium during limb regeneration (Boilly et al., 1991; Poulin and Chiu;
1995). FGF-1 (aFGF) and FGF-2 (bFGF) were found to be present in the wound

epithelium (epidermal cap) and the blastema in the regenerating limbs of the
axolotl (Biolly et al., 1991). These FGF receptors have been found spatially and

temporally distributed in a specific manner in the regenerating newt limb (Poulin
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et al., 1993; Poulin and Chiu, 1995). During the blastema stages of regeneration,

nvFGFR2 expression is localized in the wound epithelium basal layer and in the
perichodrium (bone cell precursors). In contrast, nvFGFRl was expressed

exclusively in the blastema mesenchymal cells (Poulin and Chiu, 1995). This
expression is consistent with the idea that FGF might be in the wound epithelium
and involved in the signaling for limb outgrowth during regeneration.

The primary objective of this research project was to determine the expression

patterns of FGFRs during limb regeneration in Xenopus laevis, which loses the
ability to regenerate its limbs after metamorphosis. Therefore, this system can

reveal differences in growth factor presence and action. For this, we have
selected five FGFRs cloned from Xenopus laevis and we have examined their

expression via in situ hybridization and by immunofluorescence. Having
correlated expression of two receptors (xFGFR-1 and xFGFR-2) with the ability

for limb regeneration, we examined the input of their function by using specific

inhibitors. In addition, we will also present data demonstrating induction of limb

regeneration in stage 61 (post-metamorphic and non-permissive) amputated
froglet host limbs when the wound epithelium from stage 53-55 (premetamorphic and permissive) is transplanted.

MATERIALS AND METHODS

Reagents

Unless otherwise specified, all materials were analytical reagents of the

highest grade commercially available from Acros Organics (Princeton, NJ),

Aldrich Chemical Company (Milwaukee, WI), Atlanta Biochemicals (Norcross,
GA), Boehringer Mannheim (Indianapolis, IN), Fisher Scientific (Pittsburgh,
PA), Miles, Inc.(Indianapolis. IN), Oxford Labware (St. Louis, MO), Sigma
Chemical Company (St.Louis, MO), and Vector Laboratories (Burlingham, CA),

and were used without further purification.

Animals

Laboratory bred tadpoles were purchased from Xenopus One Inc., WI and

kept at room temperature in dechlorinated tapwater (One drop Stress-Coat

Aquarious Water Conditioner, lml/lgal mixed with food, Aquarious
Pharmaceuticals, Inc, PA) maintained under oxygenation. The animals were put
on a twelve hour light cycle and were fed two to three times daily. The feeding

and cleaning procedure were as follows. 1. Tanks were cleaned every other day
by brush and fresh tap water. While the animals were netted, the tank was filled

with de-chlorinated tap water to give the animals an inch of swimming room. 2.

Two teaspoons of powdered food (provided by Xenopus-One, MI) were added to
a 1 L blender filled with 250ml tap water with the inclusion of a drop of
dechlorinator. The mixture was then blended to a uniform color or until all
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granules dissipated. 3. This mixture was then added to each tank until the tank

was barely cloudy.
Tadpoles were staged prior to amputation according to Nieuwkoop and Faber
(1976) for each experiment. A total of 100 tadpoles were used in the expression

studies and 140 for inhibitor studies. Tadpoles were amputated at stages 53 (premetamorphic) at which regeneration is possible and stage 61 (post-metamorphic),

when amputation produces a cartilagenous spike. At the correct stages, tadpoles

were anaesthetized using 1% 3-aminobenzoic acid ethyl ester (Sigma Chemical
Company) or by submerging animals in chilled water (3-6° C) prior to dissection.
Due to the delicate nature and small size of the limbs, a surgical scalpel and

diamond sharp forceps (Roboz Surgical Instruments Company, Inc., MD) were
used to remove the presumptive ankle region of the hindlimb in the early tadpoles

and to remove tissue below the knee in the post-metamorphic limb. Tissues for
expression studies were then collected and fixed at 3 days, 10 days and 15 days

post-amputation. Animals that were used for inhibitor studies were sacrificed
after a period of 23 days.
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Probes
xFGFR-1
Received from: Robert Freisel, Red Cross Laboratories, Maryland
Vector: pBluescript SK DH5alpha
Antibiotic Resistance: Ampicillin
Cloned in BamHl site
Antisense Promotor: T3 Digested With: Xhol
Sense Promotor: T7 Digested With: Xbal
Genbank Accession number: M55163
xFGFR-2
Received from: Robert Freisel, Red Cross Laboratories, Maryland
Vector: pBluescript SK DH5alpha
Antibiotic Resistance: Ampicillin
Cloned in BamHl site
Antisense Promotor: T7 Digested With: Notl or Xba
Sense Promotor: T3
Digested With: Kpnl or Xhol
Genbank Accession number: MM62322

xFGFR-3
Received from: Dr. Ikuko Hongo Dr. H. Okamoto, Ibaraki, Japan
Vector: pBluescript II SK- DH5alpha
Antibiotic Resistance: Ampicillin
Cloned in EcoRV
Antisense Promotor: T3 Digested With: AccI
Sense Promotor: T7 Digested With: Notl
Genbank Accession number: AB007035
xFGFR-4a
Received from: Dr. Ikuko Hongo Dr. H. Okamoto, Ibaraki, Japan
Vector: pBluescript II SK- DH5alpha
Antibiotic Resistance: Ampicillin
Cloned in EcoRV
Antisense Promotor: T3 Digested With: Hind III
Sense Promotor: T7 Digested With: Xbal
Genbank Accession number: AB007036

xFGFR-4b
Received from: Dr. Ikuko Hongo & Dr. H. Okamoto, Ibaraki, Japan
Vector: pBluescript II SK- DH5alpha
Antibiotic Resistance: Ampicillin
Cloned in EcoRV
Antisense Promotor: T7 Digested With: BamHl
Sense Promotor: T3 Digested With: Hindlll
Genbank Accession number: AB007036
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In situ hybridization

200 limbs that were used for expression studies were processed for paraffin
embedding using in situ hybridization precautions because it is extremely
important to keep all samples sterile of contamination, since any RNAse will
confound these experiments. All tools and glassware were either autoclaved or

baked and all solutions were either autoclaved or filtered. Tissues were first

rinsed in a 1:1 lx phospate-buffered-saline, pH 7.2 (PBS)/diethyl pyrocarbonate

(DEPC Acros, Princeton) then fixed in 4% paraformaldehyde in PBS (4°C)
overnight. Tissues were dehydrated through an alcohol series (30, 50, 70, 80, 95,
100%), cleared in Hemo-D (Fisher Scientific, Pittsburgh), then coated and
embedded in molten paraplast (Oxford Labware, St. Louis). Six-microns-thick

sections were cut using a Spencer model “ 820” microtome (Fisher Scientific),
allowed to spread in pre-warmed DEPC, and mounted on vectabond (following

company’s protocal; Vector laboratories, Burlingham) pretreated and cleaned
slides. These sections were melted on a slide warmer at 45°C for 30 minutes and
kept at 4°C until ready for use.
The sections were processed for in situ hybridization using protocols provided
by the Boehringer Mannheim (Indianapolis) Digoxygenin (DIG)-labeled RNA

method with slight modifications according to Furlow et al. (1997). Plasmids
containing FGFR genes were digested with the appropriate restriction enzymes.
Riboprobes (both antisense and sense- see above) were made using either T7,

Sp6 or T3 RNA polymerase and labeled using the DIG RNA kit from Boehringer-

Mannheim. Slides were placed on a slide warmer (45°C) for 20 minutes, then
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dewaxed in Hemo-D (Fisher-Scientific) until paraffin was removed. All

solutions were made in DEPC water unless otherwise stated. Slides were

rehydrated in an ethanol series then post-fixed in 4% paraformaldehyde (room
temperature, pH 7.2) and digested with 250 pg/ml pepsin on a slide warmer

(37° C) for 7 to 12 minutes. The slides were then fixed again in 4%
paraformaldehyde for 10 minutes and washed in lx PBS/DEPC. Sections were
then acetylated in 0.25% acetic anhydride in trichloroethanolamine (pH 8.0) for

10 minutes and washed again in lx PBS/DEPC. Tissues were rehydrated in an

ethanol series and allowed to dry on a slide warmer at 45° C . Antisense and
sense DIG labeled probes were diluted to 1000-1500 ng/ml with hybridization

solution (50% Formamide, ImM EDTA, lOmM Tris/HCl pH 7.5, 600 mM NaCl,
0.25%SDS, 10% PEG 6000, lx Denhardt’s solution and 200 ug/ml yeast tRNA)
and heat denatured at 85°C for 5 minutes. Probes were incubated with sections in
separate moist chambers (sense and antisense groups) and kept at 60°C overnight

(16 hours). The next day, all washes took place at 55°C in a water bath with the

exception of 5x SSC. First, slides were washed at 5xSSC briefly, then treated in

RNase solution (Fisher-Scientific) for 30 minutes and washed in 2xSSC for 1
hour and O.lxSSC for an additional hour. The slides were briefly rinsed in buffer
1 (0.1M Tris/HCl pH 7.6, 0.15 M NaCl) for 5 minutes. The slides were blocked

in buffer 2 (0.1M Tris/HCl pH 7.6, 0.15 M NaCl made with 10% heat inactivated
horse serum) for 1 hour. They were then incubated for 2 hours with anti-DIG
antibody conjugated to alkaline phosphatase (Boehringer-Mannheim) prepared in
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buffer 2 which was modified to 1% heat inactivated horse serum in a humidified

chamber of buffer 1. Slides were not allowed to dry throughout the entire
immunological detection procedure. Slides were then washed 4x at 5 minutes in

buffer 1 and incubated 10 minutes in buffer 3 (lOOmM Tris/HCl pH 9.5, lOOmM
NaCl, 50mM MgCf) and developed in NBT/BCIP (nitroblue

tetrazolium/bromochloroindoylphosphate from Boehringer-Mannheim) for 2-18
hours.

Immunofluorescence Antibody Staining

6 pm-thick sections were cut and deparaffmized in Hemo-D for 10 minutes or
until paraffin was removed. Tissues were rehydrated by ethanol series. During
the embedding procedure, limbs were fixed in 4% paraformaldehyde. This

presented an autofluorescence problem that was overcome by treating the sections
with 0.1% sodium borohydride in PBS (pH 8.0) for 3 cycles at 10 minutes.

Saponin (Sigma) was used to add permeability to cell membranes, which enabled
antibodies to bind to the intracellular receptor complex. A mixture of 0.1%
saponin/10% goat serum/PBS pH 7.2 was made to dilute both primary and

secondary antibodies. Antibodies were purchased from Santa Cruz

Biotechnologies. Rabbit polyclonal antibodies for FGFR-1 (fig; epitope
corresponding to amino acids 808-822 at the carboxy terminal with no cross
reactivity to bek, FGFR-3 or FGFR-4 as described by company) was used at a

1:30 dilution. FGFR-2 (bek; epitope corresponding to amino acids 789-802 at the
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carboxy terminus with no cross-reactivity to fig, FGFR-3 or FGFR-4 as described
by company) was used at a 1:30 dilution. These antibodies have been shown to

cross-react with amphibian systems, specifically in the newt (Notphthalmus

viridescens) and in the frog (Ranapipins) by McDevitt et al. (1997). Anti-rabbit
IgG conjugated with FITC (Fluorescein isothiocyanate; Vector Laboratories) was
used at a 1 GOO dilution for immunodetection. Negative controls for these

antibodies involved applying the secondary antibody to tissues without the
primary antibody. In addition, we performed positive tests for these antibodies on

newt tissues (regenerating eye and limb) and mouse testes.

Inhibitors
Six inhibitors, specific to FGFR-1 and FGFR-2, were used to characterize

the importance of these receptors in the process of limb regeneration.

Tyrophostin A-23 was purchased from Calbiochem (La Jolla, Ca) and 5 synthetic

oxindole-based inhibitors, namely SU5402, SU4984, SU76516, SU76636 and
SU76568 were provided by Dr. McMahon (from Sugen, Inc., San Francisco,

Ca). All inhibitors were made soluble in 100% dimethylsulfoxide (DMSO;

200pl), then mixed with water/food at approximately 250 ml (final

concentration=27 pM) per 30 animals. This concentration was determined from
previous in vivo in-lab experiments and in vitro studies with 3T3 cells

(Mohammadi et al., 1997). The pre-metamorphic (stage 53) animals were
immersed in inhibitor solution post-amputation and kept in this solution for 23

days after amputation. Since DMSO has been demonstrated to not affect the limb
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regeneration process at these concentrations, DMSO-treated controls were not
used (Tsonis et ah, 1994). This treatment was found to be the least toxic on the
animals.

At the end of the experiment, control (untreated premetamorphic hindlimbs)
and treated limbs were fixed in Bouin’s fixative (at least 24h). These limbs were
then rinsed in 70% alcohol and decalcified in 5% trichloroacetic acid (TCA) in

70% alcohol for 48 hours. The limbs then underwent dehydration by ethanol
series, were cleared and infiltrated with a 1:1 solution of 100% xylene: 100%
ETOH, embedded in paraplast and sectioned six-microns-thick onto pretreated

slides. Those limbs that underwent regeneration to the finger stage were whole
mount stained for cartilage with a 1% Victoria Blue B in 70% ethanol (Aldrich
Chemicals). These limbs were then stored in 100% methyl benzoate (Sigma
Diagnostics, St. Louis). Treated limbs that grew spikes, or did not match the

control group morphologically, were embedded and sectioned using a microtome
and stained with Harris hematoxylin modified solution and 1% eosin Y in 95%
ethanol (Sigma Diagnostics, St. Louis).

Victoria Blue Staining

Bouin’s fixative was removed from regenerated limbs with 2% ammonium
hydroxide solution for 48 hours with frequent changes. The limbs were immersed

in 10% hydrogen peroxide for depigmentation (time varies), dehydrated 1 hour in

50% and 1 hour in 70% ethanol and stained with 1% Victoria Blue B dissolved in
70% alcohol for 2 hours. The limbs were then de-stained via a graded ethanol
31

series up to 95% ethanol until the stain was at a desired level. For storage, the
limbs were placed in methyl benzoate and pictures were taken by a CCD
videocamera viewed with an Olympus stereoscopic microscope.

Hematoxylin and Eosin Y Staining
Tissue sections were placed in 100% xylene until all wax was removed.
Tissues were hydrated with a graded ethanol series (100, 95, 75, 55, 35%) to tap

water. Once hydrated to tap water, tissues were place in hematoxylin until
sections began to appear blue (approximately 2 minutes). Tissues were

immediately rinsed in tap water to remove excess dye, then transferred back to
ethanol for dehydration up to 95% ethanol and placed in Eosin Y (diluted to 1%
in 95% ethanol) for a short time until desired pink color stain was obtained.
Tissues were washed in absolute ethanol, further dehydrated in 100% xylene and

a cover slide was mounted with 100% permount (Fisher Scientific, Pittsburgh).

Transplantation Experiment
30 tadpoles at stage 53 were amputated following surgical guidelines outlined

above and allowed to regenerate to an early cone (7 days). Wound epithelium
was carefully isolated from the regenerates and cultured for two days using

amphibian tissue media: 30% L-15, 30% Eagles medium, 9% fetal calf serum, 5%
conditional medium, 1% fungizone, 1% penicillin/streptomycin, 11.2 pg/ml
tenamycin, 15.0 pg/ml gentamycin, 10.0 pg/ml insulin, made in sterile de-
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ionized water. In order to assure that the isolated wound epithelium was

uncontaminated and that no mesenchymal cells were present, wound epithelium
was washed with serum free media (Sigma) two times and immersed in 10 pi Dil

(Indocarbocyanines; Molecular Probes, Indianapolis) in 1ml of serum free media
and allowed to incubate overnight. Dil is a cationic fluorescent dye that

accumulates on hyperpolarized membranes and translocates into the membrane of
the cultured tissue (Molecular Probes, cat., 1997). Three days prior to

transplantation, 20 post-metamorphic (stage 67-tailless) frogs were amputated at
the ankle of their hindlimbs as previously explained. Pre-metamorphic wound
epithelium was rinsed with serum free media two times and transplanted under

the first few cell layers of the healed wounds of 10 post-metamorphic frogs. The
remaining 10 frogs were used as control animals, in which, they were punctured
and treated as the experimental limbs, but no wound epithelium was transplanted.
Animals were allowed to grow and were observed for limb regeneration. Some

limbs were taken 2 weeks after implantation, imbedded in O.C.T. Compound

(Miles, Inc, IN) and processed for frozen sectioning using a cryostat. This was to
insure that the transplanted tissue had been incorporated and reorganized in the
host limb. These tissues were observed under fluorescence (rhodamine filter) and
bright-field microscopy. Intact limbs were viewed and captured by a CCD
videocamera and Sony printer.

O
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Pictures
All black and white photos were taken with an Olympus camera connected to
either an Olympus BH-2 microscope or an Olympus SZ-PT stereoscopic

microscope. All color pictures were taken with a CCD videocamera (DEI-470,

Optronics Engineering, MI) connected to either an Olympus BH-2 microscope or
an Olympus SZ-P2 stereoscopic microscope, viewed with a Sony monitor and

printed with a Sony mavigraph videoprinter.
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RESULTS
Characterization of the stages of limb regeneration in Xenopus laevis.

The normal regenerative process in Xenopus laevis tadpole limbs amputated at

pre-metamorphic stage 53 (Nieuwkoop and Faber, 1976) as depicted through
histological sections. Regenerating limbs were taken at 3, 9, 12, 15, 18, 21 and

23 days post-amputation. The following will be a description through
observation of histological and morphological structures of the normal limb
regeneration process in Aenopwx laevis'.

Epithelial Wound Healing/Dedifferentiation- 3 days post-amputation. There is no

basal lamina formed and the wound epithelium is approximately two cell layers

thick as seen through electron microcopy (Dent, 1962).
Early Cone- (see fig. 2A) 5 to 10 days post-amputation. A blastema has been
formed without apparent differentiation.

Late Cone- 11 to 15 days post-amputation. Cartilage and muscle differentiation is

easily identifiable through light microscopy.

Early Palette- (See fig. 2B) 16 to 17 days post-amputation. The apical end of the

limb bud loses its conical shape and begins to flatten out. Muscles and cartilage
become more prominent.
Late Palette- (see fig. 2C) 18 to 19 days post-amputation. The flattened end of

the limb becomes more widespread and the wound epithelium thickens.

Early Toe- 20-27 days post-amputation. Toes begin to sprout from the palette.
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Late Toe- (see fig. 2D) 25 days post-amputation. Toes go through their final
stages of regeneration.

When Xenopus laevis was amputated at post-metamorphic stage 61
(Nieuwkoop and Faber, 1976); inspection at 15 days post-amputation indicates
that normal limb regeneration does not take place. Instead, there is the formation

of a cone (as shown in expression studies; fig. 3-7), then a spike containing

cartilagenous elements (not shown), which is identical to spikes presented from
inhibitor experiments (fig. 8D, IOC and D). The post-metamorphic re-growth is
also covered by a wound epithelium. However, as it will become apparent from

our data, this is molecularly different from the wound epithelium during pre-

metamorphic regeneration.

In situ hybridizations with xFGFRs in pre-metamorphic and postmetamorphic hindlimb blastemas.

Sense and Antisense DIG labeled probes to xFGFR-1, 2, 3, 4a and 4b were used
for in situ hybridization studies with Xenopus laevis regenerating and non

regenerating hindlimbs. Since the expression patterns at 3 days and 10 days were
the same as those shown at 15 days post-amputation, we present results from the

15 day pre-metamorphic and post-metamorphic hindlimb blastemas.

At 15 days post-amputation, regenerative blastemas from stage 53 tadpoles
(Nieuwkoop and Faber, 1976) are characterized as a late cone with a wound
epithelium that has a basal layer separating it from the underlying mesenchymal
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cells. xFGFR-1 and xFGFR-2 expression was high in the wound epithelium and

mesenchyme and present in the surrounding cells of the perichondrium (fig. 3 A

and 4A, respectively). In post-metamorphic hindlimbs (stage 61), xFGFR-1 and
xFGFR-2 expression was absent from the wound epithelium, but exhibited some
expression to its underlying mesenchyme (Fig. 3B and 4B, respectively).
xFGFR-3 expression was seen in the wound epithelium, the mesenchymal cells

and in the cartilage condensations (Fig. 5A). Signal in post-metamorphic limbs
was present in both basal cell layer of the wound covering and the underlying

mesenchyme (Fig. 5B); however, when compared to the pre-metamorphic tissues,

expression was less prominent. xFGFR-4a was expressed in the wound
epithelium and mesenchyme in both the pre- and post-metamorphic hindlimbs
(Fig. 6A/B) and FGFR-4b exhibited moderate signal in the wound epithelium,

mesenchyme and in the perichondrium (Fig. 6C) of the pre-metamorphic limb.
Expression was seen in the wound epithelium basal cell layer and mesenchyme of
the post-metamorphic limb (Fig. 6D). Pre-metamorphic and post-metamorphic

hindlimb tissues presented with sense probes were used as negative controls and
were absent of expression (fig. 3B/D, 4B/D, 5B/D, FGFR4a and FGFR4b-not

shown).

Immunofluorescence with FGFR-1 and FGFR-2 presence in pre-

metamorphic and post-metamorphic hindlimb blastemas.
Although in situ hybridization results are conclusive to determine presence of

mRNA transcripts, immunohistochemistry is the more convincing technique to
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provide evidence that genes are truly being translated into proteins. We used two

primary rabbit polyclonal antibodies; one for FGFR-1 (fig) and another for
FGFR-2 (bek). Antibodies for FGFR-3, 4a and 4b were not available for the

amphibian system. Figure 7 depicts immunofluorescence staining of fig and bek

antibodies on paraffin sections of 15d regenerates from pre-metamorphic
regenerates and post-metamorphic non-regenerates as well as their respective
negative controls, fig (Fig. 7A) and bek (Fig. 7C) epitopes were present in both

the wound epithelium, its basal layer and underlying mesenchymal cells in the

pre-metamorphic regenerating limb; however, antibodies (fig and bek) did not
detect protein presence in post-metamorphic stumps (Fig. 7 B/D, respectively)

and the negative controls show low background (7E/F).

Effect of FGFR Inhibitors on Xenopus laevis limb regeneration.

In situ hybridization and immunofluorescence expression studies have indicated
that FGFR-1 and FGFR-2 are present in Xenopus laevis ’ pre-metamorphic
regenerative limbs (stage 53), but absent in post-metamorphic froglet non-

permissive limb stumps (stage 61). This demonstrates that FGFR-1 and FGFR-2
might be important signaling molecules from the wound epithelium correlated

with the limb regeneration ability. In order to connect FGFR expression with a

function during limb regeneration, we have used Tyrophostin A-23 and 4
Oxindole based compound inhibitors (SU5402, SU4984, SU76568, SU76516 and

SU76636) to halt the FGFR signal transduction pathway.
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Tyrophostin-A23 is a broad range tyrosine kinase inhibitor, demonstrating its

ability to inhibit growth factor signal transduction in vitro (Yaish et el., 1988) and
its derivatives that are produced due to its instability in solution, have been shown
to inhibit FGF receptor signaling in vitro (Ramdas et ah, 1995). Oxindole-based
inhibitors have been shown to affect both FGFR-1 and FGFR-2.

After amputation, animals were separated into groups of 30 per tank and

treated with each inhibitor solution for 23 days, at which point we terminated this
experiment. We then compared the treatment effects on limb regeneration. These
results are presented in Table 2. Controls (untreated limbs) showed normal

regeneration and by 23 days they were at the toe stage (fig. 8A). However, in the

majority of the treated animals, regeneration was inhibited. Inhibition of the
regeneration was characterized by the presence of only a cone or spikes, which

are reminiscent of the outgrowth after amputation of post-metamorphic limbs.

Tyrophostin A-23 was capable of effecting the regeneration process in 74% of

limbs tested (Table 2; percentages represent the total # of limbs affected/total
limbs for each group). SU76568 had the most profound inhibiting effect on

regenerating limbs with a inhibition rate of 96%, followed by SU5402 at an
inhibition of 90%, while SU76516 showed inhibition in 89% of the limbs,
SU76636 in 82% and SU4984 in 68%. In the control group, we observed that
only 13% of the limbs were delayed, without apparent abnormalities.

The effects of inhibition on regeneration can be seen histologically in figures
8, 9 and 10. In figure 8, we compare representative regenerates (external view)

for different groups, taken at 23 days. In the control (untreated) regenerate, toes
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have re-grown (figure 8A). In figure 8B, we can observe a regenerate that has
been arrested at early cone stage due to treatment with SU4984. Figure 8C shows

a SU76516-treated regenerate at a late cone stage. A cartilagenous spike
reminiscent of post-metamorphic limbs developed after Tyrophostin A-23
treatment can be seen in Figure 8D.

In figure 9, we can observe abnormal limbs that regenerated to the toe stage,

stained with Victoria Blue B which stains cartilagenous elements. In Figure 9A,

we can observe the normal limb regenerate at 23d post-amputation. SU4984
caused a duplication at the level of the autopodium resulting in two sets of two

toes (Fig. 9B). SU76516 inhibited the normal formation in the tibia/fibula area

with a fusion of these bones (Fig. 9C). An example of a hypomorphic regenerate

induced by SU76516 is shown in Figure 9D.
Further inspection of inhibited regenerates or spikes through sectioning and
staining, demonstrated that the process of regeneration in the affected limbs was

not only simply delayed, but was altered considerably (Fig. 10). Figure 10A
shows a section through an untreated regenerate 7 days after amputation. This

early cone is characterized by the presence of a wound epithelium and blastema

formation. In figure 10B, we can observe a SU4984-treated regenerate 23 days

after amputation. A small cone has been developed with considerable
disorganization. This cone shows obvious abnormality in its polarity as well,

since this section shows a well-differentiated muscle (from stump), directly

underneath the cone. In figures 10C and 10D, we show the characteristic

histology of spikes with growth elements covered by a thin layer of epithelium.
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Tyrophostin A-23 treated limbs grew spikes (Table 2) which seemed to grow
almost immediately after treatment, producing a fairly large spike by 23 days

(IOC); whereas, other spikes, such as the one depicted in figure 10D produced by

treatment with SU4984 were shorter in length.

Transplantation of Xenopus laevis regenerating hindlimb wound epithelium
to non-regenerating post-metamorphic hindlimbs.

Our studies so far have indicated the importance of FGFR-1 and FGFR-2 in
regulating limb regeneration. FGFR-1 and FGFR-2 were expressed in the wound
epithelium during limb regeneration, but were absent from the wound epithelium
in post-metamorphic, non-regenerating Xenopus laevis hindlimbs. In addition,
inhibitors affected limb regeneration. We have, therefore, deduced that the
wound epithelium must contain signals that are necessary for the onset of the limb

regeneration process. It is tempting to suggest that exogenous expression of
FGFR-1 and FGFR-2 in the wound epithelium of post-metamorphic amputated

hindlimbs should induce and restore limb regeneration in the Xenopus system. If
this were true, it would solidify the importance of FGFRs in the limb regeneration

process. Such a hypothesis can be pursued by creating transgenic Xenopus that
would be capable of expressing these receptors in the wound epithelium of post-

metamorphic limbs. Such experiments are feasible, but quite laborious, and
therefore, beyond the scope of the present study. We, however, pursued some

experiments which the wound epithelium from pre-metamorphic blastemas were

transplanted onto stumps of amputated post-metamorphic hindlimbs. We were
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interested in seeing if such a wound epithelium would provide the necessary

signals for the induction of limb regeneration. Indeed, we observed induction of
regeneration in a stage 67 froglet hindlimb after amputation and transplantation in

two out of ten frogs. Figure 11A shows a regenerate 25 days after amputation;
note the presence of toes connected by a web. Figure 1 IB depicts a section

through a 14d stump of a stage 67 amputated hindlimb, transplanted with stage 53

wound epithelium. The transplanted wound epithelium was treated with 1% Dil,
in order to visualize successful graft transplantation. Figure 11C is the same
section stained with hematoxylin and eosin y viewed through a bright-field
microscope.
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Figure 1:

Molecular Structure of FGFR Inhibitors

(A)

Tyrophostin A-23; the structure contains benzylidenemalosine that
incorporates its phenyl moieties of tyrosine and compete for the tyrosine
kinase substrate site of protein tyrosine kinases.

(B) SU4984; the structure contains oxindole residues that contact the tyrosine
kinase at the site in which adenine of adenosine triphosphate binds, acting as

a competitive inhibitor.
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Figure 1: Molecular Structure of FGFR Inhibitors

A

Tyrophostin A-23
£N

i

OH
3,4-ditrihydoxy-cis-cinnamonitrile

B SU4984 (example of Oxindole Based Compounds)

3-(4-(l-formylpiperazin-4-yI)-benzylidenyl)-2-indolinone

Figure 2:

Characterization of the stages of Limb Regeneration in Xenopus laevis.

Bright-field photographs taken with a stereoscopic microscope; 9x
magnification. Stage 53 Xenopus laevis regenerating hindlimbs at 7d (A),

14d (B), 18d (C) and 24d (D) post-amputation: (A) represents an early cone
(B) represents a late cone/early palette, (C) represents a late palette, (D)

represents a late finger regenerate.
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Figure 3:
In situ hybridizations with xFGFR-1 in pre-metamorphic and post-

metamorphic hindlimb blastemas. Paraffin sections through a Xenopus

laevis regenerating hindlimb blastema (stage 53,15 days post-amputation;
(A) Antisense and (C) Sense). xFGFR-1 shows expression in the wound

epithelium (we) and the mesenchyme (m). Paraffin sections through a
Xenopus laevis non-regenerating hindlimb blastema (Stage 61,15 days post
amputation; (B) Antisense and (D) Sense). xFGFR-1 highly expresses only
in the mesenchymal tissue (m) but is absent from the wound epithelium(we).
Pictures were taken with a bright-field microscope (magnification at 400x)

by CCD videocamera.
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A

C

Figure 4:
In situ hybridizations with xFGFR-2 in pre-metamorphic and postmetamorphic hindlimb blastemas. Paraffin sections through a Xenopus
laevis regenerating hindlimb blastema (stage 53,15 days post-amputation;

(A) Antisense and (C) Sense). xFGFR-2 is expressed in the wound epithelium
(we) and mesenchymal tissue (m), and perichondrium (p). Paraffin sections
through a Xenopus laevis non-regenerating hindlimb blastema (Stage 61,15

days post-amputation; (B) Antisense and (D) Sense). xFGFR-2 is absent
from the wound epithelium but is present in the mesenchyme (m). Pictures
were with a bright-field microscope (magnification at 400x) by CCD

videocamera.
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Figure 5:

In situ hybridizations with xFGFR-3 in pre-metamorphic and postmetamorphic hindlimb blastemas. Paraffin sections through Xenopus laevis
regenerating hindlimb blastema (stage 53,15 days post-amputation; (A)

Antisense and (C) Sense; although cartilage cannot be seen, no presence was
detected in sense tissue). xFGFR-3 shows expression in the wound
epithelium (we), mesenchyme and in the cartilage condensations (c).

Paraffin sections through a Xenopus laevis non-regenerating hindlimb
blasrema (Stage 61,15 days post-amputation; (B) Antisense and (D) Sense).
xFGFR-3 shows expression in the mesenchyme and in the basal layer of the

wound epithelium (arrow). Pictures with a bright-field microscope
(magnification at 400x) by CCD videocamera.
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Figure 6:

In situ hybridizations with xFGFR-4a and xFGFR-4b in pre-metamorphic

and post-metamorphic hindlimb blastemas. Paraffin sections through a

Xenopus laevis regenerating hindlimb blastema (stage 53,15 days post
amputation); xFGFR-4a shows high expression in the wound epithelium
(we), mesenchyme (m) and in the cartilage condensations (c). (B) Paraffin
sections of a Xenopus laevis non-regenerating hindlimb blastema (Stage 61,

15 days post-amputation); xFGFR-4a shows high expression in the wound
epithelium as well as its underlying mesenchyme (m). (C) Paraffin sections

through a Xenopus laevis regenerating hindlimb blastema (stage 53,15 days
post-amputation); xFGFR-4b shows expression in the wound epithelium

(we), mesenchyme (m) and around the perichondrium (p). (D) Paraffin
sections of a Xenopus laevis non-regenerating hindlimb (Stage 61,15 days

post-amputation); XFGFR-4b expression is present in the basal cell layer of

the wound epithelium and in the mesenchymal tissues. Pictures were with a

bright-field microscope (magnification at 400x) by CCD videocamera.
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Figure 7:
Immunofluorescence: FGFR-1 and FGFR-2 presence in pre-metamorphic and

post-metamorphic hindlimb blastemas. (A) Paraffin sections through a
Xenopus laevis regenerating hindlimb blastema (stage 53,15 days post
amputation); FGFR-1 (fig) shows high expression in the wound epithelium

(we), mesenchyme (m) and in the cartilage condensations (c). (B) Paraffin
sections of a Xenopus laevis non-regenerating hindlimb (Stage 61,15 days

post-amputation); FGFR-1 (fig) is absent from the wound epithelium (we)
as well as its underlying mesenchyme. (C) Paraffin sections through a

Xenopus laevis regenerating hindlimb blastema (stage 53,15 days post
amputation); FGFR-2 (bek) shows expression in the wound epithelium (we)
only. (D) Paraffin sections of a Xenopus laevis non-regenerating hindlimb

(Stage 61,15 days post-amputation); FGFR-2 (bek) is absent from these
tissues. (E,F) Negative controls depicting paraffin sections through 15-day
Xenopus laevis hindlimb blastemas (stage 53 and stage 61, respectively).

Pictures were taken with a fluorescent microscope at a magnification of 200x.
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Figure 8:

Effects of Tyrophostin A-23 and Oxindole inhibitors on Xenopus laevis
regeneration. Bright-field photographs taken of stage 53 Xenopus laevis
regenerating hindlimbs at 23d post-amputation; all pictures were taken with

a stereoscopic microscope; 9x magnification. (A) represents a normal

regenerated limb at 23 days post-amputation. (B) represents an early cone
when treated with SU4984 for 23 days post-amputation. (C) represents a late
cone when treated with SU4984 for 23 days post-amputation. (D) represents

a spike when treated with Tyrophostin A-23 for 23 days post-amputation.
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Figure 9:

Victoria Blue B cartilage staining of control and inhibited limbs.
23 day post-amputated Xenopus laevis regenerated limbs were stained with
Victoria Blue B, pictures taken by a CCD videocamera under stereoscopic
microscope at a magnification of 6x. (A) represents a normal regenerated

hindlimb (t; tibia, f; fibula). (B) represents a limb affected by SU4984; a
duplication (d) has occurred at the distal end of tibiafibularis region,

producing mirror image skeletal elements; note the tibiafibularis is fused
(fu). (C) represents a limb affected by SU76516; the limb has been fused (fu)

at the tibiafibularis region. (D) represents a limb affected by SU76636; the
limb has toe deformations (lack of growth) and abnormalities (a).
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Figure 10:
Effects of Tyrophostin A-23 and Oxindole-based inhibitors on Xenopus laevis

regeneration (sections). Hematoxylin and Eosin Y stained paraffin sections.
(A) represents a normal 7d regenerating early cone (400x); wound

epithelium (we) is a few layers thick, cartilage condensations (c) are forming

behind the mesenchymal tissues (m). (B) represents a SU4984-treated 23d
regenerating early cone demonstrating tissue disorganization (200x). (C)

represents a Tyrophostin A-23-treated 23d regenerative spike formed with

little evidence of muscle and skeletal elements (lOOx). (D) represents a
SU4894-treated 23d regenerative spike that is abnormal and with a smaller

form (lOOx). Pictures were taken under a bright-field microscope by a CCD
videocamera.
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Figure 11:
Transplantation of Xenopus laevis regenerating hindlimb wound epithelium

to non-regenerating post-metamorphic amputated limbs offers patterned re

growth: (A) represents re-growth in a stage 67 amputated hindlimb
transplanted with stage 53 regenerative wound epithelium tissue after 25
days taken by stereoscopic microscope (9x); re-growth is incomplete ( 3

digits) and a web has formed. (B) represents a 14d stage 67 amputated
hindlimb transplanted with stage 53 regenerative wound epithelium tissue
conjugated with Dil dye taken by fluorescent microscope with a rhodamine
filter (200x); the wound epithelium tissue has migrated and reorganized the
host tissue, (C) bright-field representation of (B) stained with hematoxylin

and eosin Y. Fluorescence and bright-field pictures were taken by CCD

videocamera.
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)le 2: Effects of Tyrophostin A-23 and Oxindole on Limb Regeneration
b Regeneration
Srowth Stage

es
< Cone
Cone
< Palette
Palette
< Finger
Finger
Total:

SU5402

SU4894

SU76636 SU76516

SU76568

Tyrophostin A-23

Controls

18
23
15
1
2
2
1

6
12
10
9
1
1
2

4
8
11
0
3
2
0

8
7
10
0
0
2
1

2
13
11
0
1
0
0

14
16
10
5
5
2
2

(
I
!
3’
3:
2I
!

62

41

28

28

27

54

11:

90.32%

68.29%

82.14%

89.29%

96.30%

74.07%

12.50°/

Percentages=Total # of Early/Late/Spikes/Total Limbs

DISCUSSION

We have demonstrated that there are five FGF receptors that are present in the

wound epithelium and underlying mesenchyme during Xenopus laevis limb

regeneration (figures 3-7). xFGFR-1 and xFGFR-2 expression is absent from

the wound epithelium in post-metamorphic hindlimb outgrowth when Xenopus
laevis loses its ability for normal limb regeneration (Figures 3B, 4B and 7B and
D). The expression patterns are consistent with what is known about FGFR
presence in developing and regenerating limbs.

In developing mouse limb buds, FGFR-1 (fig) expression is distributed in the
mesenchyme and its expression is related to the onset of newly differentiated

structures. FGFR-2’s (bek) expression surrounded the surface ectoderm as well

as the mesenchymal condensations, whereas FGFR-3 has been primarily found in

the cartilage rudiments of the limb and FGFR-4 in striated muscle (Orr-Urtreger
et al., 1991; Stark et al., 1991). In the regenerating newt limb, nvFGFR-1 was
highly expressed in the mesenchyme but not in the wound epithelium, and
nvFGFR-2, as well as its spliced variants bek and KFGR. were expressed in the

wound epithelium and mesenchyme (Poulin et al., 1993; Poulin and Chiu, 1995).
One difference between FGFR-1 expression between the newt and the frog is that

FGFR-1 is expressed in the Xenopus wound epithelium. This is probably a
species-specific difference between the two regenerating systems.
Clearly, the expression patterns for FGFR-1 and FGFR-2 presented in this

study suggest a role of these receptors in limb regeneration. However, the most
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convincing evidence that FGFRs are the regeneration signals is offered when pre-

metamorphic stage 53 tadpoles amputated limbs were treated with FGFR

inhibitors. After Xenopus laevis loses its ability to regenerate due to changes
occurring through metamorphosis, amputation thereafter results in a disorganized

cone or a cartilagenous spike. Our results demonstrate that morphologically

similar spikes are generated when FGFR inhibitors were used during the normal
process of regeneration (Figures 8D, 10C-D). Since our expression analysis

showed that xFGFR-1 and xFGFR-2 were only present in the wound epithelium

of the pre-metamorphic regenerating limbs, we can deduce that the wound

epithelium does contain the regenerative signals linked to the FGF signaling
pathway. Our preliminary transplantation studies support this and might provide

a meaningful extension in inducing regeneration in vertebrate models.
Our expression analysis with xFGFR-3, xFGFR-4a and xFGFR4b suggests
that these receptors are important in the maintenance of pre-metamorphic limbs.

xFGFR-3 expression in regenerating limbs seems to correlate with the developing
limb in its expression in cartilage formation. Since xFGFR-4a and 4b have not
been detected for presence in developing or regenerating limbs, our data might

suggest that they play roles in post-metamorphic spike formation.

Identifying the signal for regeneration is of paramount importance to the field.

For example, are these signals common in limb, eye, liver and tail regeneration?
Can the regenerative abilities in newts be unified under a molecular mechanism?

After lens removal in the newt, a regenerating lens appears to grow only from the

dorsal iris by dedifferentiation of pigmented epithelial cells (McDevitt, 1997).
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Interestingly, FGF and their receptors are expressed and control lens
differentiation (Robinson et al., 1995). Furthermore, FGFR-1 expression is

confined in the dorsal iris, and inhibition of its function with an FGFR-1 specific
inhibitor results in the arrest of lens regeneration (Del Rio-Tsonis et ah, 1997
unpublished). In this sense FGFR-1 seems as important for lens regeneration as

for limb regeneration. Comparative research, analogous to the one outlined in
this paper, can be extended to other regenerative systems, for example in mice,

which are capable of regenerating only their digit tips once amputated (Borgens,

1982; Mahmood et ah, 1995; Reginelli, et ah, 1995).

We have investigated signals that permit limb regeneration and have used
the Xenopus model because comparisons can easily be made between premetamorphic tadpoles and post-metamorphic frogs. Our results provides
evidence that FGFR-1 and FGFR-2 are crucial factors involved in the induction of

limb regeneration. Extension of these studies to other models of regeneration and
animals through transgenesis might lead to the development of an animal system
where genetic manipulation is easier and can establish new models for

regeneration research.
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CONCLUSIONS

1. Through expression studies, we demonstrate that FGFR-1 and FGFR-2 show
patterns correlated with the induction ability of Xenopus to regenerate its

limbs.
2. Furthermore, by inhibiting FGFRs, we demonstrate that limb regeneration is

inhibited or shows characteristics as seen in post-metamorphic amputated
limbs.
3. These experiments point to a crucial role of wound epithelium signals in

regulating limb regeneration.
4. The wound epithelium is capable of inducing limb regeneration in postmetamorphic limbs upon transplantation.
5. Extension of these studies in other animals or in the employment of transgenic

technologies could lead to new genetic models for limb regeneration.
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ABBREVIATIONS

a
AER
ATP
BCIP
c
DAG
DEPC
DIG
DMSO
ETOH
f
FGF
FGFR
FITC
GAG
GTP
HS
IP3
m
mRNA
NBT
P
PBS
PEG
PIP2
PLC
PTK
Tyr

abnormal
apical ectodermal ridge
adenosine triphosphase
bromochloroindoylphosphate
cartilage condensations
diacylglycerol
diethyl pyrocarbonate
digoxigenin
dimethyl sulfoxide
ethyl alcohol
fibula
fibroblast growth factors
fibroblast growth factor receptors
fluorescein isothiocyanate
glycosaminoglycan
guanosine triphosphate
heparin sulfate
inositol 1,4,5-triphosphate
mesenchyme
messenger ribonucleic acid
nitroblue tetrazolium
periosteum
phosphate-buffered-saline
polyethylene glycol
phosphatidylinositol 4,5,-bisphosphate
phospholipase C
protein tyrosine kinase
tyrosine
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